1. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines 
Matthew Bennett, MD (Co-Chair), Ratika Parkash, MD, Pablo Nery, MD, Mario Sénéchal, MD, Blandine Mondesert, MD, David Birnie, MD, Laurence D. Sterns, MD, Claus Rinne, MD, Derek Exner, MD, François Philippon, MD (Co-Chair), Debra Campbell, RN, Jafna Cox, MD, Paul Dorian, MD, Vidal Essebag, MD, Andrew Krahn, MD, Jaimie Manlucu, MD, Franck Molin, MD, Michael Slawnych, MD, Mario Talajic, MD 
Canadian Journal of Cardiology 
Volume 33, Issue 2, Pages (February 2017)
DOI: /j.cjca
Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions

2. Figure 1
Aid in decision-making for primary prevention ICD. ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction; MI, myocardial infarction; OMT, optimal medical therapy.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions

3. Figure 2
Aid in decision-making for secondary prevention ICD. ICD, implantable cardioverter defibrillator; MI, myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions

4. Figure 3
(A) Conventional dual chamber, dual coil transvenous implantable cardioverter defibrillator (ICD). Arrows point to the atrial lead, the right ventricular (RV) high-voltage lead with dual coils (RV and superior vena cava [SVC]). (B) Subcutaneous ICD. Arrows point to the entirely subcutaneous components; the generator in the mid/posterior-axillary line and the subcutaneous defibrillation lead tunneled in the left parasternal subcutaneous tissue. Both pictures from the same 19-year-old patient. (B) Courtesy of Dr Philippon.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2016 Canadian Cardiovascular Society Terms and Conditions